HUP0302521A3 - Neurotrophic tacrolimus analogs, pharmaceutical compositions containing them and their use - Google Patents

Neurotrophic tacrolimus analogs, pharmaceutical compositions containing them and their use

Info

Publication number: HUP0302521A3
Authority: HU; Hungary
Prior art keywords: neurotrophic; pharmaceutical compositions; compositions containing; tacrolimus analogs; tacrolimus
Prior art date: 2000-12-29

Application number

HU0302521A

Other languages

Hungarian (hu)

Original Assignee

Astellas Pharma Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-12-29

Filing date

2001-12-31

Publication date

2007-03-28

2001-12-31 Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc

2003-11-28 Publication of HUP0302521A2 publication Critical patent/HUP0302521A2/en

2007-03-28 Publication of HUP0302521A3 publication Critical patent/HUP0302521A3/en

Links

QJJXYPPXXYFBGM-LFZNUXCKSA-N Tacrolimus Chemical class C1C[C@@H](O)[C@H](OC)C[C@@H]1\C=C(/C)[C@@H]1[C@H](C)[C@@H](O)CC(=O)[C@H](CC=C)/C=C(C)/C[C@H](C)C[C@H](OC)[C@H]([C@H](C[C@H]2C)OC)O[C@@]2(O)C(=O)C(=O)N2CCCC[C@H]2C(=O)O1 QJJXYPPXXYFBGM-LFZNUXCKSA-N 0.000 title 1
230000000508 neurotrophic effect Effects 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Immunology (AREA)
Diabetes (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Psychiatry (AREA)
Psychology (AREA)
Epidemiology (AREA)
Emergency Medicine (AREA)
Obesity (AREA)
Hospice & Palliative Care (AREA)
Hematology (AREA)
Endocrinology (AREA)
Transplantation (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Packages (AREA)
Medical Preparation Storing Or Oral Administration Devices (AREA)
Saccharide Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

HU0302521A 2000-12-29 2001-12-31 Neurotrophic tacrolimus analogs, pharmaceutical compositions containing them and their use HUP0302521A3 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US25850000P	2000-12-29	2000-12-29
PCT/US2001/050419 WO2002053159A1 (en)	2000-12-29	2001-12-31	Neurotrophic tacrolimus analogs

Publications (2)

Publication Number	Publication Date
HUP0302521A2 HUP0302521A2 (en)	2003-11-28
HUP0302521A3 true HUP0302521A3 (en)	2007-03-28

Family

ID=22980816

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HU0302521A HUP0302521A3 (en)	2000-12-29	2001-12-31	Neurotrophic tacrolimus analogs, pharmaceutical compositions containing them and their use

Country Status (18)

Country	Link
EP (1)	EP1353671A4 (en)
JP (1)	JP2004527472A (en)
KR (2)	KR20070030331A (en)
CN (1)	CN1293877C (en)
AR (1)	AR035411A1 (en)
AU (1)	AU2002231277B2 (en)
BR (1)	BR0116762A (en)
CA (1)	CA2433384A1 (en)
CZ (1)	CZ20032060A3 (en)
HU (1)	HUP0302521A3 (en)
IL (1)	IL156664A0 (en)
MX (1)	MXPA03005941A (en)
NO (1)	NO20032913D0 (en)
NZ (1)	NZ527209A (en)
PL (1)	PL366301A1 (en)
RU (1)	RU2288716C2 (en)
WO (1)	WO2002053159A1 (en)
ZA (1)	ZA200305806B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2003901023A0 (en) *	2003-03-04	2003-03-20	Fujisawa Pharmaceutical Co., Ltd.	New use
EP1706117A1 (en) *	2004-01-20	2006-10-04	Astellas Pharma Inc.	Method for treating erectile dysfunction
EP1810675A1 (en) *	2006-01-18	2007-07-25	Institut Curie	Method for treating Huntington's disease by inhibiting dephosphorylation of huntingtin at S421
JP2009102226A (en) *	2006-02-14	2009-05-14	Meiji Milk Prod Co Ltd	Spinal cord injury treatment
US9149459B2 (en)	2008-07-23	2015-10-06	Novartis Ag	Sphingosine 1 phosphate receptor modulators and their use to treat muscle inflammation
JP2015511242A (en) *	2012-02-23	2015-04-16	インセルム（インスティチュートナショナルデラサンテエデラリシェルシェメディカル）	Calcineurin inhibitors for use in the treatment of pathological vestibular disorders
GB201309375D0 (en) *	2013-05-24	2013-07-10	Chronos Therapeutics Ltd	Medical methods and compounds for medical use

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US537663A (en) *		1895-04-16		wubstee
ATE120466T1 (en) *	1987-12-09	1995-04-15	Fisons Plc	MACROCYCLIC COMPOUNDS.
GR1001225B (en) *	1989-09-14	1993-06-30	Fisons Plc	Novel macrocyclic compositions and new application method thereof
US5534520A (en) *	1990-04-10	1996-07-09	Fisher; Abraham	Spiro compounds containing five-membered rings
US5541193A (en) *	1991-09-05	1996-07-30	Abbott Laboratories	Heterocycle-containing macrocyclic immunomodulators
GB9202196D0 (en) *	1992-02-01	1992-03-18	Fisons Plc	Method of treatment
GB9218027D0 (en) *	1992-08-25	1992-10-14	Fisons Plc	Novel method of treatment
US5696135A (en) *	1995-06-07	1997-12-09	Gpi Nil Holdings, Inc.	Inhibitors of rotamase enzyme activity effective at stimulating neuronal growth
US5968921A (en) *	1997-10-24	1999-10-19	Orgegon Health Sciences University	Compositions and methods for promoting nerve regeneration
GB9917158D0 (en) *	1999-07-21	1999-09-22	Fujisawa Pharmaceutical Co	New use

2001
- 2001-12-27 AR ARP010106058A patent/AR035411A1/en unknown
- 2001-12-31 MX MXPA03005941A patent/MXPA03005941A/en active IP Right Grant
- 2001-12-31 WO PCT/US2001/050419 patent/WO2002053159A1/en not_active Ceased
- 2001-12-31 NZ NZ527209A patent/NZ527209A/en unknown
- 2001-12-31 AU AU2002231277A patent/AU2002231277B2/en not_active Ceased
- 2001-12-31 PL PL01366301A patent/PL366301A1/en not_active Application Discontinuation
- 2001-12-31 KR KR1020077003889A patent/KR20070030331A/en not_active Ceased
- 2001-12-31 RU RU2003123493/15A patent/RU2288716C2/en not_active IP Right Cessation
- 2001-12-31 CA CA002433384A patent/CA2433384A1/en not_active Abandoned
- 2001-12-31 BR BR0116762-6A patent/BR0116762A/en not_active Application Discontinuation
- 2001-12-31 CN CNB018228860A patent/CN1293877C/en not_active Expired - Fee Related
- 2001-12-31 EP EP01991558A patent/EP1353671A4/en not_active Withdrawn
- 2001-12-31 JP JP2002554109A patent/JP2004527472A/en not_active Ceased
- 2001-12-31 IL IL15666401A patent/IL156664A0/en unknown
- 2001-12-31 HU HU0302521A patent/HUP0302521A3/en unknown
- 2001-12-31 KR KR1020037008787A patent/KR100794204B1/en not_active Expired - Fee Related
- 2001-12-31 CZ CZ20032060A patent/CZ20032060A3/en unknown
2003
- 2003-06-24 NO NO20032913A patent/NO20032913D0/en not_active Application Discontinuation
- 2003-07-28 ZA ZA2003/05806A patent/ZA200305806B/en unknown

Also Published As

Publication number	Publication date
BR0116762A (en)	2004-08-10
CZ20032060A3 (en)	2004-01-14
RU2003123493A (en)	2005-01-20
NO20032913D0 (en)	2003-06-24
EP1353671A4 (en)	2004-07-14
KR20040007431A (en)	2004-01-24
CN1538843A (en)	2004-10-20
PL366301A1 (en)	2005-01-24
KR100794204B1 (en)	2008-01-14
AR035411A1 (en)	2004-05-26
KR20070030331A (en)	2007-03-15
JP2004527472A (en)	2004-09-09
CA2433384A1 (en)	2002-07-11
ZA200305806B (en)	2005-01-26
AU2002231277B2 (en)	2006-11-30
RU2288716C2 (en)	2006-12-10
HUP0302521A2 (en)	2003-11-28
NZ527209A (en)	2005-09-30
CN1293877C (en)	2007-01-10
IL156664A0 (en)	2004-01-04
MXPA03005941A (en)	2005-02-14
WO2002053159A1 (en)	2002-07-11
EP1353671A1 (en)	2003-10-22

Similar Documents

Publication	Publication Date	Title
HUP0204514A3 (en)	2004-07-28	Pyridinylimidazoles, pharmaceutical compositions containing them and their use
HUP0401109A3 (en)	2007-12-28	Nociceptin analogs, their use and pharmaceutical compositions containing them
HUP0301573A3 (en)	2004-03-29	Substituted arylpyrazines, pharmaceutical compositions containing them and their use
HUP0400837A3 (en)	2007-11-28	2-phenyl-thiazole derivatives, their use and pharmaceutical compositions containing them
HUP0204474A3 (en)	2004-07-28	1h-imidazopyridine derivatives, pharmaceutical compositions containing them and their use
HUP0400467A3 (en)	2012-08-28	2-iminopyrrolidine derivatives, pharmaceutical compositions containing them and their use
HUP0400784A3 (en)	2007-09-28	Bicyclic heterocondensated pyrrolcarboxamide derivatives, their use and pharmaceutical compositions containing them
HUP0200308A2 (en)	2002-06-29	Quinolinecarboxamides as antiviral agents, pharmaceutical compositions containing them and their use
HUP0200714A3 (en)	2003-01-28	Pharmaceutical compounds, pharmaceutical compositions containing them and their use
HUP0300207A3 (en)	2005-07-28	1,2,3,4-tetrahydroisquinoline derivatives, pharmaceutical compositions containing them and their preparation processes
DZ3311A1 (en)	2001-09-07	Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof
HUP0600592A2 (en)	2006-11-28	Substituted imidazopyridines, pharmaceutical compositions containing them and intermediates
HUP0204081A3 (en)	2003-07-28	4-pyrimidinyl-n-acyl-l-phenylalanines, pharmaceutical compositions containing them and their use
HUP0402003A3 (en)	2005-06-28	Substituted 1,4-benzodiazepines, pharmaceutical compositions containing them and uses thereof
HUP0400967A3 (en)	2004-10-28	Substituted 2-anilino-benzimidazoles, their use and pharmaceutical compositions containing them
HUP0203194A3 (en)	2004-01-28	Phenylpiperazines, pharmaceutical compositions containing them and their use
HUP0203735A3 (en)	2005-03-29	4-pyridinyl-n-acyl-l-phenylalanines, pharmaceutical compositions containing them and their use
HUP0500024A3 (en)	2009-01-28	6-aminomorphinane derivatives, their use and pharmaceutical compositions containing them
HUP0400179A3 (en)	2004-10-28	2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylpyrimidines, their use and pharmaceutical compositions containing them
HUP0203645A3 (en)	2004-01-28	Phenylpiperazinyl derivatives, pharmaceutical compositions containing them and their use
IL153907A0 (en)	2003-07-31	PHARMACEUTICAL COMPOSITIONS CONTAINING 2-METHYLENE-19-NOR-20(S)-1alpha, 25-DIHYDROXYVITAMIN D3
HUP0402028A3 (en)	2008-03-28	Unsaturated 1-amino-alkylcyclohexane derivatives, pharmaceutical compositions containing them and use thereof
HUP0303469A3 (en)	2004-04-28	Phtalazinon-derivatives, their use and pharmaceutical compositions containing them
HUP0401644A3 (en)	2008-03-28	Aminobenzoephenones, pharmaceutical compositions containing them and use thereof
HUP0401713A3 (en)	2012-08-28	Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same

Legal Events

Date

Code

Title

Description

2006-03-28

GB9A

Succession in title

Owner name: ASTELLAS PHARMA INC., JP

Free format text: FORMER OWNER(S): FUJISAWA PHARMACEUTICAL CO., LTD., JP

2009-09-28

FD9A

Lapse of provisional protection due to non-payment of fees